ASHPOfficial

Learn from experts in the field on strategies for preventing controlled substances diversion and associated risk. Topics include waste minimization, controlled substance prevention program value proposition and position justification, auditing best practices, and creating an efficient – yet compliant – OR throughput. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Vicki Basalyga sits down with Katelyn Dervay, who relays how her time and training as an Emergency Medicine Pharmacist and experience on medical missions in Haiti translates to caring for patients as a Civilian Inpatient Pharmacist at Landstuhl Regional Medical Center. Katelyn shares what shaped her career, what she has learned along the way and how she integrated what she was passionate about into an exciting and dynamic pharmacy career. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast we discuss with Dr. Andrea Luebchow, Program Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of Pharmacy Leadership, Vicki Basalyga sits down with Doug Slain to discuss his experiences as an international Antibiotic Stewarship Consultant and his involvement with U.S.-Thai Consortium for the Development of Pharmacy Education in Thailand and the unique leadership opportunities offered in these roles. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are recipients of the Distinguished Service Award for service to the Section and ASHP as demonstrated by sustained contributions and activities that support ASHP's mission and vision and advance the profession. Discussion will involve their career paths, current or past activities they most enjoyed, and where they envision informatics in the future. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

EM Pharmacists and Physicians are in a unique position where they are able to see every stage of alcohol withdrawal arrive in the emergency department. With this setting, EM Pharmacists and Physicians have the ability to dramatically impact the course of a patient’s hospitalization or ED visit. This podcast episode will critically evaluate the monitoring and management of patients in alcohol withdrawal, specifically from the emergency department perspective. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, we meet with Ashlee Klevens Hayes, pharmacist and executive career strategist to discuss self-trust, a key component to the value of wellbeing and resilience. Ashlee shares 10 tangible tools to help develop this skill through new habits, conquer imposter syndrome, and help you excel through transitionary phases in your career. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses ASHP and other healthcare organizations releasing a series of policy and marketplace recommendations to address significant challenges in our nation's drug supply chain that have been exacerbated by the COVID-19 pandemic. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This case presentation from the Midyear Clinical Meeting 2020 shares the methods by which two rural community hospitals in a newly formed healthcare-system worked together to modify many aspect of everyday operations to respond to their health-system's COVID-19 response, including medication management, infection prevention, and treatment protocol development. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists play an important role in emerging areas, including gene-based and cell-based therapies. Excerpts from this 2020 Midyear Clinical Meeting Presentation share how pharmacists can recommend processes for safe handling of cell- and gene-based therapies, meet standards for storage and preparation of these therapies, and prepare their departments to provide these therapies as more become available. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Brush up on your pediatric medication safety with this excerpt from Section of Clinical Specialists and Scientists’ presentation from the 2020 Midyear Clinical Meeting. Our content matter experts review the purpose of the KIDs list, teach how to assess if a medication is safe to use in pediatrics, and explain why a medication may not be safe to use in the pediatric population. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses the need for Medicare coverage of pharmacy services related to ordering oral antivirals for COVID-19. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

For new preceptors, staying on top of clinical responsibilities and all of the learning goals and objectives of your residents can be difficult. Tools that help that transition can make a world of difference. In this episode of Educator Essentials, we discuss using a weekly roadmap to help preceptors and their residents on the track to success. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The COVID-19 pandemic has presented several challenges for pharmacist-run anticoagulation clinics. In this 2020 Midyear Clinical Meeting presentation, Yale New Haven Pharmacists share their approach to adjusting clinic in-person visit workflows to continue to provide high-quality patient care and monitoring while adequately protecting patients and staff. They describe their remote methods to monitor anticoagulation therapy and identify their successes with intradepartmental communication. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Planned in cooperation with Section of Pharmacy Practice Leaders, this podcast episode helps the listener identify the five principles that are required for a high-performing team, summarizes ways teamwork can positively impact individuals and the organization, and identifies strategies to overcome challenges that may arise within a team. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the Section of Ambulatory Care Practitioners’ presentation at the 2020 Midyear Clinical Meeting, our content matter experts review the most appropriate continuous glucose monitor based on patient-specific factors and design a patient-centered diabetes treatment plan using continuous glucose monitoring data. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drs. Janet Silvester, Julie Dagam, and Jamie Kalus discuss the benefits and impact of standardizing pharmacy residency programs within multi-entity health systems, with respect to the perspectives of both the accrediting body and the residency programs. They share areas and example policies that would benefit from standardization, as well as go over the challenges faced during the alignment process. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode highlights the key takeaways from the ASHP Section of Clinical Specialists and Scientists’ 2020 Midyear Clinical Meeting presentation on how pharmacists can recommend therapy interventions for a patient with COPD to reduce exacerbation or hospital readmission. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode describes how ASHP incorporated yoga practice into the workplace, the benefits, and how you can bring the practice into your workplace and life. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

COVID-19 required the pharmacy referral service within the Family Medical Practice at Penn Presbyterian Medical Center to move to a virtual platform. This podcast episode, originally presented at the 2020 Midyear Clinical Meeting, describes the implementation of the pharmacy services as well as results of the transition for maintaining patient care visits and pharmacy residency training during a pandemic. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode reviews updates to the Physician Fee Schedule and their effect on ambulatory care pharmacy practice. Listeners will receive an overview of the Physician Fee Schedule and its impact on various scenarios pharmacists may encounter in practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this featurette from the 2020 Midyear Clinical Meeting, our content matter expert shares the proposed mechanisms for augmented renal clearance in critically ill adult or pediatric patients and evaluate the clinical risk factors for augmented renal clearance. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this fun, informative presentation format brought to you by the Section of Clinical Specialists and Scientists from the 2020 Midyear Clinical Meeting, content matter experts share GI and nutrition clinical “gems” of information that can be applied across practice settings. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode looks at successful opioid stewardship programs and the approaches the programs use to be successful. The moderator and guests discuss methodologies and strategies to help listeners better understand how to implement a successful opioid stewardship program at their site. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The 2020 ASHP Midyear Clinical Meeting was an adjustment for all members who attended, particularly for residency candidates as they navigated a virtual residency showcase and PPS. Join members of the Pharmacy Student Forum and the New Practitioners Forum as they share insights from the 2020 meeting and highlight tips on preparing for the virtual setting and making the most of your experience at the 2021 Midyear Clinical Meeting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join Brittany Tschaen as she sits down with Joe Marchiano and Rena Gosser who will share their lessons learned and best practices for attending the virtual Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the virtual platform. Later in the episode, Brittany sits down with three program chairs from the 2021 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with William Zellmer to discuss Dr. Oddis’s career and his contributions to the pharmacy profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with Paul Abramowitz, ASHP CEO, to talk about his many fond memories of Dr. Oddis. They discuss how Dr. Oddis’s leadership and vision laid the foundation for ASHP to evolve into the successful organization it is today. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tune in to this podcast episode on acute kidney biomarker testing and how pharmacists may apply acute kidney injury biomarkers in their clinical practice. From the 2020 Midyear Clinical Meeting, content matter experts explore the use of NGAL and TIMP-2*IGFBP-7 in clinical practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This episode will review the current paradigm shift from trough concentration-guided vancomycin dosing and therapeutic drug monitoring (TDM) to area under the concentration-time curve (AUC)-guided vancomycin dosing and TDM and will prepare pharmacists for this paradigm shift and provide real-world examples of AUC monitoring implementation by multiple methods. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Purchase the recertification product here. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Accuracy in diagnosis is critical for treating infectious diseases. In honor of U.S. Antibiotic Awareness Week (November 18-24, 2021), this Therapeutic Thursday podcast episode features an expert from the CDC and a physician and epidemiologist from the University of Maryland School of Medicine in Baltimore, Maryland. Our guests discuss diagnostic and antibiotic stewardship and how disease overestimation during diagnosis impacts antimicrobial prescribing behaviors. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on contemporary diagnosis and management of C diff infection. Topics include new diagnostic strategies and best treatment plans for our patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Embedded Clinical Pharmacists at Penn Presbyterian Medical Center’s clinics serve as members of an interdisciplinary team that confirm clinical appropriateness of specialty medications, ensure medication access, provide medication counseling and the specialty pharmacy complies with Utilization Review Accreditation Commission (URAC) regulations to maintain accreditation status. With the advent of COVID-19, these serves shifted to a telemedicine approach. In her 2020 Midyear Clinical Meeting presentation, Dr. Diane Kim shares her institution’s successes with transition and how her team demonstrated value to the specialty services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Brought to you by the Section of Ambulatory Care Practitioners, this podcast episode features excerpts from the 2020 Midyear Clinical Meeting Design disease focused progressive pharmacy care models for a rural population and features virtual or telehealth models to reach rural-based populations, examples of standardized approaches for key rural practice areas, and identifies barriers faced in rural care settings. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In Part One of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated acute respiratory distress syndrome and shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated ARDS. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The opioid needs for a palliative care patient do not follow the same rules as pain management. In this highlight from the 2020 Midyear Clinical Meeting, content matter experts from the Section of Ambulatory Care Practitioners compare and contrast the difference in therapy goals between opioid tapering in the palliative care population and the general population and compare possible opioid tapering regimens for both a general population patient and a palliative care patient. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode provides members with an overview of FDA’s new draft hospital and health system compounding guidance. We cover what’s changed from the previous draft guidance, what it means for practice and compliance, and what comes next with FDA advocacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, we explore the importance of paying it forward by serving as poster mentors for student pharmacists and residents. We discuss best practices in coaching learners through the research process and tips on how to effectively evaluate poster presentations to assist learner’s professional development. For those interested in inspiring and motivating learners in the ASHP Midyear Clinical Meeting and Exhibition 2021 Poster Hall, sign up to be a poster mentor by November 15. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.